| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1996;93:889-897.)
© 1996 American Heart Association, Inc.
Articles |
Role of Angiographically Identifiable Thrombus on Long-term Luminal Renarrowing After Coronary Angioplasty
A Quantitative Angiographic Analysis
Presented in part at the 43rd Annual Meeting of the American College of Cardiology, Atlanta, Ga, March 13-17, 1994, and the 16th Annual Congress of the European Society of Cardiology, Berlin, Germany, September 10-14, 1994.
From the Catheterization Laboratory, Thoraxcenter, Erasmus University, and the Department of Epidemiology and Biostatistics, Cardialysis (R.M.), Rotterdam, Netherlands.
Correspondence to Prof P.W. Serruys, MD, PhD, FACC, FESC, Catheterization Laboratory, Thoraxcenter, Erasmus University Rotterdam, Postbus 1738, 3000 DR Rotterdam, Netherlands.
Background Experimental studies suggest that mural thrombus may be involved in postangioplasty restenosis. The aim of our study was to examine the role of angiographically identifiable thrombus in the clinical situation.
Methods and Results The study population comprised 2950 patients (3583 lesions). The presence of angiographically identifiable thrombus either before or after the procedure was defined as the presence of a generalized haziness or filling defect within the arterial lumen. Restenosis was assessed by both a categorical (>50% diameter stenosis at follow-up) and a continuous approach (absolute and relative losses). The study population included 160 lesions with and 3423 lesions without angiographically identifiable thrombus. The categorical restenosis rate was significantly higher in lesions containing angiographically identifiable thrombus: 43.1% versus 34.4%, P<.01; relative risk, 1.449; CI, 1.051 to 1.997. The absolute and relative losses were also higher in lesions containing angiographically identifiable thrombus (absolute loss, 0.43±0.66 versus 0.32±0.52; relative loss, 0.16±0.26 versus 0.13±0.21; both P<.05). The higher restenosis in these lesions was due primarily to an increased incidence of occlusion at follow-up angiography in this group: 13.8% versus 5.7%, P<.001. When lesions that went on to occlude by the time of follow-up angiography were excluded from the analysis, the restenosis rate between the two groups was similar by both the categorical (34.1% versus 30.4%, P=NS; relative risk, 1.183; CI, 0.824 to 1.696) and continuous (absolute loss, 0.23±0.46 versus 0.24±0.42, P=NS; relative loss, 0.09±0.17 versus 0.09±0.16, P=NS) approaches.
Conclusions Our results indicate that the presence of angiographically identifiable thrombus at the time of the angioplasty procedure is associated with higher restenosis. The mechanism by which this occurs is through vessel occlusion at follow-up angiography. Measures aimed at improving outcome in this group of patients should be focused in this direction.
Key Words: angioplasty • thrombus • angiography • trials • meta-analysis
This article has been cited by other articles:
 |
|
 |
|
  L De Luca, G Sardella, C J Davidson, G De Persio, M Beraldi, T Tommasone, M Mancone, B L Nguyen, L Agati, M Gheorghiade, et al. Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction Heart, July 1, 2006; 92(7): 951 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Rezkalla and D. R. Holmes Jr Lipid-rich plaque masquerading as a coronary thrombus. Clin. Med. Res., June 1, 2006; 4(2): 119 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Constantinides, T S N Lo, M Been, and M F Shiu Early experience with a helical coronary thrombectomy device in patients with acute coronary thrombosis. Heart, May 1, 2002; 87(5): 455 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Singh, G. S. Reeder, E. M. Ohman, V. Mathew, W. B. Hillegass, R. D. Anderson, D. S. Gallup, K. N. Garratt, and D. R. Holmes Jr Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty? An angiographic trials pool data experience J. Am. Coll. Cardiol., September 1, 2001; 38(3): 624 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kageyama, H. Yamamoto, and R. Yoshimoto Anti-Human von Willebrand Factor Monoclonal Antibody AJvW-2 Prevents Thrombus Deposition and Neointima Formation After Balloon Injury in Guinea Pigs Arterioscler Thromb Vasc Biol, October 1, 2000; 20(10): 2303 - 2308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Waugh, J. Li-Hawkins, E. Yuksel, M. D. Kuo, P. N. Cifra, P. R. Hilfiker, R. Geske, M. Chawla, J. Thomas, S. M. Shenaq, et al. Thrombomodulin Overexpression to Limit Neointima Formation Circulation, July 18, 2000; 102(3): 332 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Okamura, M. Ohishi, H. Rakugi, T. Katsuya, Y. Yanagitani, S. Takiuchi, Y. Taniyama, K. Moriguchi, H. Ito, Y. Higashino, et al. Pharmacogenetic Analysis of the Effect of Angiotensin-Converting Enzyme Inhibitor on Restenosis After Percutaneous Transluminal Coronary Angioplasty Angiology, October 1, 1999; 50(10): 811 - 822. [Abstract] [PDF]
|
|
|
|
|
|
C. E. Buller, V. Dzavik, R. G. Carere, G. B. J. Mancini, G. Barbeau, C. Lazzam, T. J. Anderson, M. L. Knudtson, J.-F. Marquis, T. Suzuki, et al. Primary Stenting Versus Balloon Angioplasty in Occluded Coronary Arteries : The Total Occlusion Study of Canada (TOSCA) Circulation, July 20, 1999; 100(3): 236 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Mariani, Y. J. Gu, P. W. Boonstra, J. G. Grandjean, W. van Oeveren, and T. Ebels Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate? Ann. Thorac. Surg., May 1, 1999; 67(5): 1370 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Oltrona, P. R. Eisenberg, J. M. Lasala, D. J. Sewall, M. E. Shelton, and K. J. Winters Association of Heparin-Resistant Thrombin Activity With Acute Ischemic Complications of Coronary Interventions Circulation, November 1, 1996; 94(9): 2064 - 2071. [Abstract] [Full Text]
|
|